Christian Thiede
Christian Thiede
Professor of Molecular Hematology, University of Technics Dresden
Verified email at uniklinikum-dresden.de
Title
Cited by
Cited by
Year
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis …
C Thiede, C Steudel, B Mohr, M Schaich, U Schäkel, U Platzbecker, ...
Blood 99 (12), 4326-4335, 2002
18422002
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
E Bayerdörffer, B Rudolph, A Neubauer, C Thiede, N Lehn, S Eidt, ...
The Lancet 345 (8965), 1591-1594, 1995
11841995
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
N Engl J Med 369, 111-121, 2013
11302013
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
11072017
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
C Thiede, S Koch, E Creutzig, C Steudel, T Illmer, M Schaich, G Ehninger, ...
Blood 107 (10), 4011-4020, 2006
8462006
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ...
Blood 131 (12), 1275-1291, 2018
5482018
T (11; 18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication
H Liu, H Ye, A Ruskone–Fourmestraux, D De Jong, S Pileri, C Thiede, ...
Gastroenterology 122 (5), 1286-1294, 2002
4792002
Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
A Neubauer, C Thiede, B Alpen, M Ritter, B Neubauer, G Ehninger, ...
Journal of the National Cancer Institute 89 (18), 1350-1355, 1997
3901997
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
U Platzbecker, M Wermke, J Radke, U Oelschlaegel, F Seltmann, A Kiani, ...
Leukemia 26 (3), 381-389, 2012
3552012
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group
M Sackmann, A Morgner, B Rudolph, A Neubauer, C Thiede, H Schulz, ...
Gastroenterology 113 (4), 1087-1090, 1997
3521997
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
T Wündisch, C Thiede, A Morgner, A Dempfle, A Günther, H Liu, H Ye, ...
Journal of clinical Oncology 23 (31), 8018-8024, 2005
3402005
Long-term follow-up of gastric MALT lymphoma after
T Wundisch, C Thiede, A Morgner, A Dempfle, A Gunther, H Liu, H Ye, ...
Helicobacter pylori, 8018-24, 0
340*
Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection
C Thiede, M Florek, M Bornhäuser, M Ritter, B Mohr, C Brendel, ...
Bone Marrow Transplantation 23 (10), 1055-1060, 1999
3211999
Helicobacter heilmannii–associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection
A Morgner, N Lehn, LP Andersen, C Thiede, M Bennedsen, K Trebesius, ...
Gastroenterology 118 (5), 821-828, 2000
3202000
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients
T Illmer, US Schuler, C Thiede, UI Schwarz, RB Kim, S Gotthard, D Freund, ...
Cancer research 62 (17), 4955-4962, 2002
3172002
Helicobacter and gastric MALT lymphoma
M Stolte, E Bayerdörffer, A Morgner, B Alpen, T Wündisch, C Thiede, ...
Gut 50 (suppl 3), iii19-iii24, 2002
3112002
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial
H Serve, U Krug, R Wagner, MC Sauerland, A Heinecke, U Brunnberg, ...
Journal of Clinical Oncology 31 (25), 3110-3118, 2013
3092013
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2 …
C Röllig, H Serve, A Hüttmann, R Noppeney, C Müller-Tidow, U Krug, ...
The lancet oncology 16 (16), 1691-1699, 2015
2902015
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German …
J Schetelig, C Thiede, M Bornhauser, R Schwerdtfeger, M Kiehl, J Beyer, ...
Journal of Clinical Oncology 21 (14), 2747-2753, 2003
2812003
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes
U Krug, C Röllig, A Koschmieder, A Heinecke, MC Sauerland, M Schaich, ...
The Lancet 376 (9757), 2000-2008, 2010
2792010
The system can't perform the operation now. Try again later.
Articles 1–20